| |
| |
|
| Insider
Information: |
Katabi Maha |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
3,181,442 |
|
|
Indirect Shares
|
12,626,622 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
15,808,064 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vera Therapeutics, Inc. |
VERA |
Director |
2022-02-10 |
3,181,442 |
2024-03-25 |
2,793,987 |
Premium* |
|
|
Aerovate Therapeutics, Inc. |
AVTE |
Director, 10% Owner |
2021-07-02 |
0 |
2021-07-02 |
3,758,686 |
Premium* |
|
|
Cincor Pharma, Inc. |
CINC |
10% Owner |
2022-01-11 |
0 |
2022-08-11 |
6,073,949 |
Premium* |
|
|
Rayzebio, Inc. |
RYZB |
|
2023-09-19 |
0 |
2024-02-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VERA |
Vera Therapeutics, Inc. |
Director |
– • – |
2024-03-25 |
4 |
S |
$40.50 |
$13,770,000 |
I/I |
(340,000) |
2,793,987 |
0 |
- |
|
| VERA |
Vera Therapeutics, Inc. |
Director |
– • – |
2024-03-22 |
4 |
S |
$40.51 |
$16,748,860 |
I/I |
(413,450) |
3,133,987 |
0 |
- |
|
| VERA |
Vera Therapeutics, Inc. |
Director |
– • – |
2024-03-21 |
4 |
S |
$43.00 |
$3,580,723 |
I/I |
(81,009) |
3,547,437 |
0 |
- |
|
| RYZB |
Rayzebio, Inc. |
|
– • – |
2024-02-26 |
4 |
D |
$62.50 |
$151,220,500 |
I/I |
(2,419,528) |
0 |
0 |
- |
|
| VERA |
Vera Therapeutics, Inc. |
Director |
– • – |
2024-01-30 |
4 |
B |
$31.00 |
$4,999,990 |
I/I |
161,290 |
3,628,446 |
2.1 |
- |
|
| RYZB |
Rayzebio, Inc. |
Director |
– • – |
2023-09-19 |
4 |
B |
$18.00 |
$8,499,996 |
I/I |
472,222 |
1,209,764 |
2.1 |
% |
|
| RYZB |
Rayzebio, Inc. |
Director |
– • – |
2023-09-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,947,306 |
973,653 |
0 |
- |
|
| CINC |
Cincor Pharma, Inc. |
10% Owner |
– – • |
2022-08-11 |
4 |
B |
$30.00 |
$15,000,000 |
I/I |
500,000 |
6,073,949 |
1.5 |
- |
|
| VERA |
Vera Therapeutics, Inc. |
Director |
– • • |
2022-02-10 |
4 |
B |
$15.00 |
$3,999,990 |
D/D |
266,666 |
3,181,442 |
3.92 |
- |
|
| CINC |
Cincor Pharma, Inc. |
10% Owner |
– – • |
2022-01-11 |
4 |
B |
$16.00 |
$5,200,000 |
I/I |
325,000 |
5,573,949 |
1.5 |
- |
|
| CINC |
Cincor Pharma, Inc. |
10% Owner |
– – • |
2022-01-11 |
4 |
A |
$0.00 |
$0 |
I/I |
5,248,949 |
5,248,949 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
Director |
– • • |
2021-07-02 |
4 |
B |
$14.00 |
$4,999,988 |
I/I |
357,142 |
3,758,686 |
2.25 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
Director |
– • • |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,401,544 |
3,401,544 |
0 |
- |
|
| VERA |
Vera Therapeutics, Inc. |
Director |
– • • |
2021-05-18 |
4 |
B |
$11.00 |
$7,999,992 |
I/I |
727,272 |
2,914,776 |
2.25 |
- |
|
| VERA |
Vera Therapeutics, Inc. |
Director |
– • • |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,187,504 |
2,187,504 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
